Lisanti Capital Growth, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 369 filers reported holding REPLIGEN CORP in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$2,248,401
-41.1%
14,140
-30.7%
0.36%
-30.5%
Q3 2022$3,820,000
+78.3%
20,415
+54.8%
0.51%
+75.6%
Q2 2022$2,142,000
-50.8%
13,190
-19.7%
0.29%
-53.8%
Q4 2021$4,351,000
-11.4%
16,430
-3.4%
0.63%
-13.0%
Q3 2021$4,913,000
+372.0%
17,000
+226.0%
0.72%
+461.2%
Q2 2021$1,041,000
-57.9%
5,215
-59.0%
0.13%
-59.3%
Q1 2021$2,471,000
-66.3%
12,710
-66.8%
0.32%
-68.8%
Q4 2020$7,332,000
+30.8%
38,261
+0.7%
1.02%
-2.2%
Q3 2020$5,604,000
+31.5%
37,981
+10.2%
1.04%
+19.4%
Q2 2020$4,262,000
-48.7%
34,481
-59.9%
0.87%
-68.3%
Q1 2020$8,306,000
+45.0%
86,040
+38.9%
2.74%
+80.4%
Q4 2019$5,730,000
+141.9%
61,947
+100.5%
1.52%
+96.6%
Q3 2019$2,369,000
-69.0%
30,895
-65.3%
0.77%
-68.9%
Q2 2019$7,653,000
+126.7%
89,040
+55.8%
2.49%
+108.0%
Q1 2019$3,376,000
+5.9%
57,135
-5.4%
1.20%
-7.1%
Q4 2018$3,187,000
+29.4%
60,420
+36.1%
1.29%
+50.5%
Q3 2018$2,463,000
+83.5%
44,405
+55.7%
0.86%
+66.7%
Q2 2018$1,342,000
+90.1%
28,525
+54.7%
0.51%
+16.1%
Q3 2017$706,000
-65.5%
18,435
-62.7%
0.44%
-67.6%
Q2 2017$2,049,000
+153.6%
49,450
+88.6%
1.36%
+39.8%
Q4 2016$808,000
+114.9%
26,225
+110.7%
0.98%
+105.5%
Q3 2016$376,000
-25.0%
12,445
-30.8%
0.48%
+5.3%
Q3 2015$501,000
-76.2%
17,977
-64.8%
0.45%
-70.3%
Q2 2015$2,107,00051,0501.52%
Other shareholders
REPLIGEN CORP shareholders Q2 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders